On May 12, 2020, the Indiana State Department of Health (ISDH) issued a document providing guidance on mitigating the use of aerosolizing respiratory treatments in long-term care facilities to minimize the risk of COVID-19 transmission, including the administration of inhaled medications via nebulizer therapy and noninvasive airway support via C-PAP and Bi-PAP.
The current recommended best practice is to shift to the use of Metered-Dose Inhalers, as opposed to nebulized treatments, for all long-term care residents, as applicable, in consultation with the resident’s medical provider.
In circumstances that require nebulizer therapy, if a resident is confirmed or suspected to be COVID-positive, the guidance offers the following strategies:
To assist health care personnel who perform or assist with aerosolizing producing procedures, IHCA/INCAL also recommends reviewing Item #11 in the CDC’s Guidance for Infection Control in Health Care Facilities, which further specifies the PPE that should be used for aerosol-generating procedures. If you have any questions, please contact Lori Davenport at firstname.lastname@example.org.